Exact Mass: 429.09292639999995
Exact Mass Matches: 429.09292639999995
Found 26 metabolites which its exact mass value is equals to given mass value 429.09292639999995
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Besifloxacin HCl
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Sulfamethoxazole N1-glucuronide
Sulfamethoxazole N1-glucuronide is a metabolite of Sulfamethoxazole. Sulfamethoxazole n1-glucuronide belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.
SMZ-PtO
C17H15N7O5S (429.08553400000005)
CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 3103 ALGAE_TP_ID 3103; CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b)
Sulfamethoxazole glucuronide
(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE
C8H25N5O11P2 (429.10257599999994)
N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide
3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile
C19H19N5O3S2 (429.09292639999995)
Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)
(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)
C23H17N4O3S (429.10213120000003)
4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide
C18H19ClF3N5S (429.10017200000004)
2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone
C19H19N5O3S2 (429.09292639999995)
(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid
C19H19N5O3S2 (429.09292639999995)
N-acetyl-L-aspartyl-L-glutamyl-L-glutamate
C16H19N3O11-4 (429.10195439999995)
3-(2-Benzo[1,3]dioxol-5-yl-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl)-benzonitrile
N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide
C21H20ClN3O3S (429.09138400000006)
4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide
C21H20ClN3O3S (429.09138400000006)
2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide
Sulfamethoxazole N1-glucuronide
UBP316
C20H19N3O6S (429.0994514000001)
UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist[1].